GEOVAX LABS, INC. Current Liabilities
GEOVAX LABS, INC. (GOVX) had Current Liabilities of $2.71 million as of 2026-06-30, per its S-1 filed 2026-09-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-09-17
- 2026-06-30: Liabilities, Current $2.71M.
- 2026-03-31: Liabilities, Current $2.29M.
- 2025-12-31: Liabilities, Current $1.94M.
- 2025-09-30: Liabilities, Current $1.82M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $2.71M S-1 · filed 2026-09-17 |
| 2026-03-31 | $2.29M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.94M S-1 · filed 2026-09-17 |
| 2025-09-30 | $1.82M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.53M 10-Q · filed 2025-07-28 |
| 2025-03-31 | $2.94M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $3.11M S-1 · filed 2026-09-17 |
| 2024-09-30 | $2.61M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $6.40M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $3.30M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.52M 10-K · filed 2025-03-27 |
| 2023-09-30 | $7.08M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $4.09M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $4.54M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $4.75M 10-K · filed 2024-02-29 |
| 2022-09-30 | $4.79M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.37M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $3.50M 10-Q · filed 2022-04-27 |
| 2021-12-31 | $5.44M 10-K · filed 2023-03-23 |
| 2021-09-30 | $335.65K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $359.02K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $451.95K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $810.31K 10-K · filed 2022-03-09 |
| 2020-09-30 | $923.65K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.79M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $2.67M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $2.02M 10-K · filed 2021-03-23 |
| 2019-09-30 | $1.81M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.64M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.64M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $1.62M 10-K · filed 2020-03-24 |
| 2018-09-30 | $1.30M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.07M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $919.44K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $811.29K 10-K · filed 2019-03-26 |
| 2017-09-30 | $731.54K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $651.59K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $547.90K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $369.85K 10-K · filed 2018-03-23 |
| 2016-09-30 | $252.59K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $180.19K 10-Q · filed 2016-08-05 |
| 2016-03-31 | $166.44K 10-Q · filed 2016-05-04 |
| 2015-12-31 | $126.99K 10-K · filed 2017-03-24 |
| 2015-09-30 | $118.22K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $181.09K 10-Q · filed 2015-08-04 |
| 2015-03-31 | $216.73K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $187.02K 10-K · filed 2016-03-16 |
| 2014-09-30 | $170.23K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $237.49K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $235.34K 10-Q · filed 2014-05-02 |
| 2013-12-31 | $312.35K 10-K · filed 2015-03-20 |
| 2013-09-30 | $225.53K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $151.61K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $349.78K 10-Q · filed 2013-05-01 |
| 2012-12-31 | $327.04K 10-K · filed 2014-03-14 |
| 2012-09-30 | $337.91K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $379.99K 10-Q · filed 2012-08-13 |
| 2012-03-31 | $510.20K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $941.53K 10-K · filed 2013-03-18 |
| 2011-09-30 | $650.06K 10-Q · filed 2011-11-10 |
| 2011-06-30 | $730.61K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $521.61K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |